Aycan and Enspectra partner for clinical trials on cellular imaging system

Radiology workflow and data management company Aycan Medical Systems has expanded into the clinical trials market. 

In a partnership with medical imaging diagnostics company Enspectra Health, Aycan provided imaging data management to support a pivotal clinical trial of Enspectra’s new VIO system. The first-of-its-kind technology visualizes, captures and stores images at the cellular level for more clinically accurate assessments of health. For now, VIO has received FDA clearance for use on skin after the successful proof-of-concept study.

According to a statement, the partnership between the two companies will be ongoing, with Enspectra utilizing Aycan cloud PACS and DICOM image archiving as it looks to conduct more trials to expand applications for VIO. 

Enspectra’s website states its cellular imaging capabilities will have a variety of clinical applications.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.